Journal article
Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC)
Abstract
Renal cell carcinoma (RCC) is one of the most lethal genitourinary malignancies. Recently, there has been a paradigm shift in the management of advanced RCC. New targeted therapies including vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) inhibitors have been developed which have shown promising results in a patient population who otherwise had very few options for treatment. The first mTOR inhibitor, …
Authors
Shahani R; Kwan KG; Kapoor A
Journal
Drug Healthcare and Patient Safety, Vol. 2, No. 0, pp. 85–91
Publisher
Taylor & Francis
Publication Date
2010
DOI
10.2147/dhps.s6467
ISSN
1179-1365